indole-3-carbinol

Small moleculeexperimental

Indole-3-carbinol (I3C, C9H9NO) is produced by the breakdown of the glucosinolate glucobrassicin, which can be found at relatively high levels in cruciferous vegetables such as broccoli, cabbage, cauliflower, brussels sprouts, collard greens and kale. It is also available in dietary supplements. Indole-3-carbinol is the subject of on-going biomedical research into its possible anticarcinogenic, antioxidant, and anti-atherogenic effects. Research on indole-3-carbinol has been conducted primarily using laboratory animals and cultured cells. Limited and inconclusive human studies have been reported. A recent review of the biomedical research literature found that "evidence of an inverse association between cruciferous vegetable intake and breast or prostate cancer in humans is limited and inconsistent" and "larger randomized controlled trials are needed" to determine if supplemental indole-3-carbinol has health benefits. — Wikipedia

Clinical trial activity

6 trials · 6 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
2
Phase 3
1
Phase 4
0

Earliest trial started Jan 1, 2002 (NCT00033345)

Timeline

2000s

  1. Jan 1, 2002

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2009

    Earliest Phase 2 Sponsor(trial)

2020s

  1. Jan 1, 2025

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

OCc1c[nH]c2ccccc12
Mol. weight
147.18 g/mol
Lipinski Ro5
Pass
Rule of 3
Yes
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 1h-indole-3-methanol
  • 3-hydroxymethylindole
  • i3c cpd
  • indole-3-carbinol
  • indole-3-carbinol
  • indole-3-carbinol
  • indole-3-carbinol
  • indole-3-methanol

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07164183Phase 3Sep 11, 2025Alcea
NCT03687073Phase 1Nov 30, 2018University of Minnesota
NCT00988845Phase 2Sep 1, 2009University of Wisconsin
NCT00607932N/AMar 1, 2005National Cancer Institute (NCI), Vanderbilt University
NCT00100958Phase 1Nov 1, 2004National Cancer Institute (NCI), University of Kansas
NCT00033345Phase 1Jan 1, 2002National Cancer Institute (NCI), University of Kansas
Showing 6 of 6 trials
Page 1 / 1

Organizations

Research & Development (6)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
National Cancer Institute (NCI)Government3022002
University of KansasAcademic/Hospital2212002
AlceaFor profit1112025
University of MinnesotaAcademic/Hospital1112018
University of WisconsinAcademic/Hospital1112009
Vanderbilt UniversityAcademic/Hospital1112005
6 organizations
Page 1 / 1